This inventor holds 1 USPTO granted patent. Top assignees: Nissan Chemical Corporation, Shionogi & Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 262 
1 out of 16 Years Active: 2026
Title: Mado Nakajima: Pharmaceutical Invention and Patent Work.
Introduction
Mado Nakajima is an inventor associated with Toyonaka, Japan. Her patent work concerns pharmaceutical compounds investigated for their potential to inhibit sepiapterin reductase, an enzyme relevant to pain treatment.
Latest Patents
The provided information lists one patent for Nakajima: “Substituted pyrazolo[1,5-a]pyrimidines as sepiapterin reductase inhibitors.” The invention describes condensed heterocyclic compounds, along with their tautomers, pharmaceutically acceptable salts, and solvates, that have sepiapterin reductase inhibitory activity and may be useful in treating pain. The patent describes substituents through a general chemical formula.
Career Highlights
Nakajima is associated with Nissan Chemical Corporation and Shionogi & Co., Ltd. Her listed patent reflects work at the intersection of medicinal chemistry and pharmaceutical research. The supplied information identifies 1 patent.
Collaborations
Masahiro Kamaura and Yusuke Inaba are listed as Nakajima’s coworkers, indicating professional connections in her research and invention-related work.
Conclusion
Mado Nakajima’s documented invention focuses on sepiapterin reductase-inhibiting compounds with potential applications in pain treatment, alongside professional associations with Nissan Chemical Corporation and Shionogi & Co., Ltd.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile